Read next
Digital Biomarkers Gain Regulatory Traction for Clinical Trials
Continuous monitoring data from wearable devices is gaining formal acceptance as secondary endpoints in clinical drug studies.
AI-Driven Clinical Trials Reduce Phase II Timeline Costs
Pharmaceutical companies leverage predictive machine learning models to optimize patient selection and reduce clinical trial attrition.
Clinical Trials Leverage Synthetic Control Arms to Expedite Drug Approval
Pharmaceutical developers are deploying real-world health data and computational models to construct synthetic control arms, shortening trial timelines.
Clinical Pipelines Pivot Toward Targeted RNA Therapies
Biotechnology firms prioritize precision genetic interventions for rare metabolic and autoimmune conditions.
Pharmaceutical Supply Chains Restructure Around Biomanufacturing Resilience
Drug manufacturers increase localized manufacturing facilities to mitigate single-source API vulnerabilities.
Pharmaceutical Supply Chains Pivot Toward Localized Biomanufacturing Facilities
Global drug manufacturers are investing in regional continuous-flow manufacturing sites to hedge against maritime logistics vulnerabilities.